What I wrote was that the Director’s Summary is not confidential.

But I’m open to the opinions of others as to whether the “Estimate of Costs” should be confidential. What do you think?

Note: I failed to include a rationale in the Director’s Summary to answer the question, “What illness is this motion designed to cure?” Version 2 will include that .

-Fred K1VR

From: David Propper [mailto:k2dp@charter.net]
Sent: Saturday, January 16, 2021 9:51 AM
To: Fred Hopengarten
Cc: ARRL ODV Mailing List
Subject: Re: [arrl-odv:31705] Concept Paper Attached

Fred,

Would it be your intention to share both the “Director’s Summary” and the “Directors Estimate of Costs” with membership , or just the “Director’s Summary” ?

Thanks for putting this together so quickly !

Dave

Dave Propper, K2DP

ARRL Midwest Division Vice Director

On Jan 15, 2021, at 9:11 PM, <hopengarten@post.harvard.edu> <hopengarten@post.harvard.edu> wrote:

To the Board:

I attach a concept paper that reflects ideas discussed yesterday, Friday, outside of the Board meeting. This is NOT A MOTION, nor do I anticipate it will become a motion until further discussion has occurred, including consideration by the Administration and Finance Committee, and Staff (so as to consider how we may handle comments from the membership).

You will note that I am a strong believer in providing examples, hoping that some examples will survive into the ultimate document so that new Board members will have an idea of Board expectations.

Comments and edits welcome anytime.

Fred Hopengarten, Esq. K1VR

Six Willarch Road

Lincoln, MA 01773

781.259.0088, k1vr@arrl.org

New England Director

<image001.png>

Serving ME, NH, VT, MA, RI and CT

Virus-free. www.avast.com

<Concept Paper for Greater Transparency for Motions Coming Before the Board.doc>_______________________________________________
arrl-odv mailing list
arrl-odv@reflector.arrl.org
https://reflector.arrl.org/mailman/listinfo/arrl-odv